First Zantac cancer risk trial in Calif. postponed five months ...Middle East

Devdiscourse - Opinion
First Zantac cancer risk trial in Calif. postponed five months
The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months. The case, brought by California resident James Goetz in Alameda County Superior Court, is now expected to go to trial July 24, according to a spokesperson for GSK.

Hence then, the article about first zantac cancer risk trial in calif postponed five months was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( First Zantac cancer risk trial in Calif. postponed five months )

Apple Storegoogle play

Last updated :

Also on site :